Implanet S.A. (EPA:ALIMP)
France · Delayed Price · Currency is EUR 0.1520
-0.0102 (-6.29%)
Oct 2, 2026, 5:35 PM CET
Implanet Revenue
Implanet had revenue of 7.14M EUR in the half year ending June 30, 2026, with 73.31% growth. This brings the company's revenue in the last twelve months to 13.80M, up 24.35% year-over-year. In the year 2025, Implanet had annual revenue of 12.47M with 32.62% growth.
Revenue (ttm)
13.80M
Revenue Growth
+24.35%
P/S Ratio
1.58
Revenue / Employee
281.63K
Employees
49
Market Cap
21.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.47M | 3.07M | 32.62% |
| Dec 31, 2024 | 9.41M | 4.90M | 108.56% |
| Dec 31, 2023 | 4.51M | -191.00K | -4.06% |
| Dec 31, 2022 | 4.70M | -1.44M | -23.44% |
| Dec 31, 2021 | 6.14M | 2.25M | 57.76% |
| Dec 31, 2020 | 3.89M | -3.52M | -47.46% |
| Dec 31, 2019 | 7.41M | 687.00K | 10.22% |
| Dec 31, 2018 | 6.72M | -1.12M | -14.30% |
| Dec 31, 2017 | 7.84M | 16.00K | 0.20% |
| Dec 31, 2016 | 7.83M | 1.17M | 17.61% |
| Dec 31, 2015 | 6.65M | -385.04K | -5.47% |
| Dec 31, 2014 | 7.04M | 348.03K | 5.20% |
| Dec 31, 2013 | 6.69M | 43.59K | 0.66% |
| Dec 31, 2012 | 6.65M | 2.13M | 47.05% |
| Dec 31, 2011 | 4.52M | 1.80M | 66.00% |
| Dec 31, 2010 | 2.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Eurobio Scientific Société anonyme | 172.26M |
| Biosynex | 95.19M |
| Diagnostic Medical Systems | 51.41M |
| Novacyt | 25.31M |
| Median Technologies | 23.47M |
| Bluelinea Société Anonyme | 11.12M |
| Mauna Kea Technologies | 8.91M |